Top Back to top

The outcome of second and third allogeneic conditioned HSCT in patients with non-SCID primary immune deficiency (PID) following primary or secondary graft failure

Inborn Errors Working Party (IEWP)
Study type:
Study number:
8427019
Type of treatment:
Allogeneic
Diseases:
 
Short title:
Outcome of second allo in non-SCID PID patients
Primary objective:
 
Key inclusion criteria:
 
Country:
 
Principal investigator:
Zohreh Nademi
EBMT Study coordinator:
Tiar Sirait
Study coordinator email:
iewp@ebmt.org